← All companies

RPRX

Royalty Pharma plc

RPRX Nasdaq Pharmaceutical Preparations EDGAR ↗

$57.17

-1.85 -3.13%

Key statistics

from XBRL data in SEC filings

Market cap

$31.8B

Revenue (TTM)

$2.44B

Net income (TTM)

$826M

EPS (TTM)

$1.90

P/E ratio

30.1

Dividend yield

1.57%

Free cash flow

—

Cash

$586M

Total assets

$19.8B

Gross margin

—

52-week range

$34.08 – $60.44

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 4, 2026 8-K Entered a material agreement; Took on a direct financial obligation May 28, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Regulation FD disclosure Apr 13, 2026 10-K Fiscal year ended 2025-12-31 Feb 11, 2026 8-K Results of operations (earnings release) Feb 11, 2026 8-K Director or officer change Dec 22, 2025 8-K Regulation FD disclosure Dec 22, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Entered a material agreement; Other events Sep 16, 2025 8-K Director or officer change Aug 13, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Director or officer change Jul 17, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Director or officer change; Amended charter or bylaws May 19, 2025 8-K Shareholder vote results May 12, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Entered a material agreement Apr 11, 2025 8-K Director or officer change Apr 10, 2025 10-K Fiscal year ended 2024-12-31 Feb 12, 2025 8-K Results of operations (earnings release) Feb 11, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jan 10, 2025 8-K Results of operations (earnings release) Jan 10, 2025 8-K Entered a material agreement; Amended charter or bylaws Dec 31, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Regulation FD disclosure Sep 27, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Regulation FD disclosure Aug 7, 2024 8-K Other events Jun 20, 2024 8-K Entered a material agreement; Took on a direct financial obligation Jun 10, 2024 8-K Shareholder vote results Jun 6, 2024 8-K Entered a material agreement Jun 4, 2024 8-K Other events May 29, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024